Ms. Sigal Fattal
Equibles does not estimate personal net worth.
Get an email with a short summary when Chemomab Therapeutics Ltd. publishes a filing, an earnings call transcript or a press release.
Get CMMB alertsAbout Ms. Sigal Fattal
Ms. Sigal Fattal is recorded as CFO at Chemomab Therapeutics Ltd. (CMMB) since June 1, 2023. Chemomab Therapeutics Ltd. reported in an 8-K filed June 5, 2023 that Ms. Sigal Fattal was appointed Chief Financial Officer, effective June 1, 2023. Chemomab Therapeutics Ltd. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Chemomab Therapeutics Ltd. includes Adi Mor (CEO and Board Member), Dale Pfost (CEO and Board Member), Dr. Adi Mor (CEO) and 7 others.
“On June 1, 2023, the Board appointed Ms. Sigal Fattal, the VP of Finance of the Company, as the Chief Financial Officer of the Company to replace Mr. Donald Marvin, effective as of the same date.”
Affiliation history
-
Current
2023-06-01–present
Company network
Leadership on record at Chemomab Therapeutics Ltd.
- Adi Mor CEO, Board Member
- Dale Pfost CEO, Board Member
- Dr. Adi Mor CEO
- Dr. Dale Pfost CEO
- Neil Cohen CEO, Board Member
- Dr. Nissim Darvish Chairman
- Stephen Squinto Chairman, Board Member
- Andrew Fine CFO
- Donald Marvin CFO, COO
- Sigal Fattal CFO